Information  X 
Enter a valid email address

Broker Forecast - Barclays Capital issues a broker note on Hikma Pharmaceuticals PLC

By BFN News | 08:40 AM | Tuesday 20 August, 2019

Barclays Capital today reaffirms its equal weight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 1900p (from 1800p). Story provided by Broker Forecasts data provided by

a d v e r t i s e m e n t